| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 98 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 52.5K | $29.88M | -20,000 | |
| CEO | 49.0K | $27.91M | -9,500 | |
| VP | Mahon Paul A | 44.5K | $25.33M | - |
| VP | 42.5K | $24.16M | - | |
| CFO | Edgemond James | 19.9K | $11.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Edgemond James46 | CFO And Treasurer | Sale+OE | 10,000 | $568.83 | $5,688,318.95 | -5.8% | - | - | |
| Apr 20, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $577.83 | $5,489,423.82 | -1.5% | - | - | |
| Apr 20, 2026 | Edgemond James46 | CFO And Treasurer | Sale+OE | 10,000 | $577.86 | $5,778,606.91 | -3.3% | - | - | |
| Mar 16, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $537.81 | $5,109,148.28 | -16.5% | - | - | |
| Mar 11, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $539.54 | $5,125,646.80 | -14.7% | - | - | |
| Mar 10, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $539.71 | $5,127,273.03 | -10.7% | - | - | |
| Mar 5, 2026 | Mahon Paul A48 | EVP &General Counsel | Sale+OE | 8,300 | $483.16 | $4,010,187.14 | -2.2% | - | - | |
| Mar 4, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 19,000 | $317.97 | $6,041,413.58 | -30.9% | - | - | |
| Mar 4, 2026 | Kurzweil Ray | Director | Sale+OE | 4,910 | $489.02 | $2,401,088.20 | -27.9% | - | - | |
| Mar 4, 2026 | Thompson Tommy G50 | Director | Sale+OE | 2,000 | $489.42 | $978,839.40 | -19.1% | - | - |